Can a 73-year-old woman with chronic constipation who is taking prucalopride (Resolor) use a weekly enema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Weekly Enema Use with Prucalopride in a 73-Year-Old Woman

Yes, she can use a weekly enema while taking prucalopride, but this suggests inadequate response to prucalopride and warrants reassessment of her treatment regimen. If she requires weekly enemas despite being on prucalopride, the medication is likely not providing sufficient relief, and her management strategy needs optimization.

Clinical Context and Reasoning

The 2023 AGA-ACG guidelines strongly recommend prucalopride for chronic idiopathic constipation in adults who don't respond to over-the-counter agents 1. Prucalopride is effective in elderly patients, with comparable efficacy in those ≥65 years compared to younger populations 1. However, the need for regular rescue therapy like weekly enemas indicates suboptimal response.

Key Considerations for This Patient

Prucalopride Efficacy in the Elderly

  • Studies specifically demonstrate that prucalopride (1-4 mg once daily) is safe and well-tolerated in elderly patients with chronic constipation 2
  • The 73-year-old age is not a contraindication; efficacy is maintained in this age group 1
  • Most patients achieve ≥3 complete spontaneous bowel movements per week with prucalopride 1

When Weekly Enemas Signal Treatment Failure

If she needs weekly enemas, consider these steps:

  1. Verify adequate prucalopride dosing: Standard dose is 2 mg daily; 1 mg daily if severe renal impairment (creatinine clearance <30 mL/min) 1

  2. Assess timing: Most side effects (headache, diarrhea) occur in the first week and resolve within days 1. If she's past this window without benefit, response is unlikely to improve

  3. Evaluate for contraindications: Prucalopride is contraindicated in intestinal perforation/obstruction, Crohn's disease, ulcerative colitis, and toxic megacolon 1

  4. Consider treatment duration: Clinical trials showed efficacy from 4-24 weeks, though the drug label doesn't specify a duration limit 1

Management Algorithm

If requiring weekly enemas after 4+ weeks on prucalopride:

  • Reassess the diagnosis: Ensure this is truly chronic idiopathic constipation and not obstructive defecation syndrome or slow-transit constipation requiring different interventions
  • Optimize prucalopride: Confirm she's on 2 mg daily (unless renal impairment)
  • Add or adjust adjunctive therapy: Prucalopride can be used alongside OTC agents 1; consider optimizing fiber, osmotic laxatives, or other agents
  • Consider alternative prescription agents: If prucalopride fails, other options include linaclotide, plecanatide, or lubiprostone per guidelines 1

Safety of Concurrent Use

There is no contraindication to using enemas while on prucalopride. The medication works systemically as a 5-HT4 agonist to stimulate colonic motility 1, while enemas provide local mechanical relief. However, regular dependence on enemas suggests the oral therapy isn't meeting treatment goals.

Common Pitfalls to Avoid

  • Don't assume prucalopride needs more time if no response by 4 weeks: The primary efficacy window is well-established in trials 1
  • Don't ignore the need for rescue therapy as "normal": Regular enema use indicates inadequate symptom control and impaired quality of life
  • Don't overlook renal function: Dose adjustment to 1 mg is critical in severe renal impairment 1
  • Monitor for mood changes: Though causality is unclear, the drug label cautions about suicidal ideation; be alert to unusual mood or behavioral changes 1

Bottom Line

While there's no safety concern with weekly enemas during prucalopride therapy, the need for them indicates treatment inadequacy. Reassess her response using validated measures (frequency of complete spontaneous bowel movements, PAC-QOL scores), verify optimal dosing, and consider escalating or changing therapy if she hasn't achieved ≥3 complete spontaneous bowel movements per week after 4-12 weeks of treatment 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.